World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
74
Citations
19761
World Ranking
2055
National Ranking
1005

Medicine

D-Index
74
Citations
19762
World Ranking
19404
National Ranking
9665

Research.com Recognitions

  • 2002 - Hellman Fellow

Overview

Edwin D. Charlebois is affiliated with the University of California, San Francisco in the United States. Their scholarly contributions primarily fall within the field of Medicine, encompassing a total of 120 publications. Within this broad domain, they have a focused interest in subfields such as Infectious Diseases, General Health Professions, Epidemiology, Virology, and Sociology and Political Science.

The scientist's research work extensively covers topics related to HIV/AIDS and sexual health, including HIV/AIDS Research and Interventions, HIV, Drug Use, Sexual Risk, Adolescent Sexual and Reproductive Health, HIV Research and Treatment, Global Maternal and Child Health, Sex Work and Related Issues, and HIV/AIDS Impact and Responses.

Recent representative papers by Edwin D. Charlebois include:

  • Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections, 2023, New England Journal of Medicine
  • Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study, 2020, The Lancet HIV
  • Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study, 2020, AIDS and Behavior
  • Drought and intimate partner violence towards women in 19 countries in sub-Saharan Africa during 2011-2018: A population-based study, 2020, PLoS Medicine
  • HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda, 2021, PLoS Medicine

Edwin D. Charlebois frequently collaborates with other researchers, with notable co-authors including Moses R. Kamya, Diane V. Havlir, Jane Kabami, Elizabeth A. Bukusi, and Maya Petersen. These collaborations reflect a cohesive network in infectious disease and HIV research.

The scientist has published multiple studies in respected venues, with frequent publications in UNC Libraries, PLoS ONE, JAIDS Journal of Acquired Immune Deficiency Syndromes, AIDS and Behavior, and PLoS Medicine. This range indicates active engagement with diverse academic platforms specializing in infectious diseases and public health.

Edwin D. Charlebois received the Hellman Fellow award in 2002.

Best Publications

  • Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

    David R. Bangsberg;Frederick M. Hecht;Edwin D. Charlebois;Andrew R. Zolopa

  • Non-adherence to highly active antiretroviral therapy predicts progression to Aids

    David R. Bangsberg;Sharon Perry;Edwin D. Charlebois;Richard A. Clark

  • High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections

    Bradley W. Frazee;Jeremy Lynn;Edwin D. Charlebois;Larry Lambert

  • Decline in HIV infectivity following the introduction of highly active antiretroviral therapy.

    Travis C Porco;Jeffrey N Martin;Kimberly A Page-Shafer;Amber Cheng

  • Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.

    Unknown

  • Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale.

    Thomas P. Giordano;David Guzman;Richard Clark;Edwin D. Charlebois

  • Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.

    Jessica H. Oyugi;Jayne Byakika-Tusiime;Edwin D. Charlebois;Cissy Kityo

  • High levels of adherence do not prevent accumulation of HIV drug resistance mutations.

    David R Bangsberg;Edwin D Charlebois;Robert M Grant;Mark Holodniy

  • Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis

    John L. Johnson;D. J. Hadad;W. H. Boom;C. L. Daley

  • Population-Based Community Prevalence of Methicillin-Resistant Staphylococcus aureus in the Urban Poor of San Francisco

    Edwin D. Charlebois;David R. Bangsberg;Nicholas J. Moss;Matthew R. Moore

  • Community-Adapted Methicillin-Resistant Staphylococcus aureus (MRSA): Population Dynamics of an Expanding Community Reservoir of MRSA

    Heather A Carleton;Binh An Diep;Edwin D. Charlebois;George F. Sensabaugh

  • Comparison of an Interferon-γ Release Assay with Tuberculin Skin Testing in HIV-infected Individuals

    Annie F. Luetkemeyer;Edwin D. Charlebois;Laura L. Flores;David R. Bangsberg

  • Provider assessment of adherence to HIV antiretroviral therapy.

    David R. Bangsberg;Frederick M. Hecht;Heather Clague;Edwin D. Charlebois

  • Dihydroartemisinin–Piperaquine for the Prevention of Malaria in Pregnancy

    Abel Kakuru;Prasanna Jagannathan;Mary K. Muhindo;Paul Natureeba

  • Increasing Prevalence of Methicillin-Resistant Staphylococcus aureus Infection in California Jails

    Erica S. Pan;Binh A. Diep;Heather A. Carleton;Edwin D. Charlebois

  • HIV Seroprevalence Among Homeless and Marginally Housed Adults in San Francisco

    Marjorie J. Robertson;Richard A. Clark;Edwin D. Charlebois;Jacqueline Tulsky

  • Theory-Guided, Empirically Supported Avenues for Intervention on HIV Medication Nonadherence: Findings from the Healthy Living Project

    Mallory O. Johnson;Sheryl L. Catz;Robert H. Remien;Mary Jane Rotheram-Borus

  • Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model.

    Mallory O. Johnson;Margaret A. Chesney;Rise B. Goldstein;Robert H. Remien

  • HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa

    Diane V Havlir;Laura B Balzer;Edwin D Charlebois;Tamara D Clark

  • Origins of Community Strains of Methicillin-Resistant Staphylococcus aureus

    Edwin D. Charlebois;Françoise Perdreau-Remington;Barry Kreiswirth;David R. Bangsberg

  • Removing barriers to knowing HIV status: same-day mobile HIV testing in Zimbabwe.

    Stephen F Morin;Gertrude Khumalo-Sakutukwa;Edwin D Charlebois;Janell Routh

  • Comparing Objective Measures of Adherence to HIV Antiretroviral Therapy: Electronic Medication Monitors and Unannounced Pill Counts

    David R. Bangsberg;Frederick M. Hecht;Edwin D. Charlebois;Margaret Chesney

Frequent Co-Authors

Diane V. Havlir
Diane V. Havlir University of California, San Francisco
Moses R. Kamya
Moses R. Kamya Makerere University
Elizabeth A. Bukusi
Elizabeth A. Bukusi University of Washington
Grant Dorsey
Grant Dorsey University of California, San Francisco
David R. Bangsberg
David R. Bangsberg Simon Fraser University
Stephen F. Morin
Stephen F. Morin University of California, San Francisco
Philip J. Rosenthal
Philip J. Rosenthal University of California, San Francisco
Harsha Thirumurthy
Harsha Thirumurthy University of Pennsylvania
Robert H. Remien
Robert H. Remien Columbia University
Margaret A. Chesney
Margaret A. Chesney University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related healthcare degrees can open diverse career opportunities. Many students consider advancing their qualifications through specialized nursing programs that complement immunology knowledge. For instance, enrolling in a nurse practitioner accelerated program offers a streamlined pathway to becoming an advanced practice nurse while applying immunological principles in patient care.

Students without prior nursing experience may find online BSN programs for non nurses particularly advantageous. These programs provide the flexibility and foundational knowledge necessary to enter the nursing field and build expertise related to immunology.

For quicker access to the nursing profession, options like the easiest accelerated nursing programs and fastest and easiest LPN programs offer practical routes. These pathways allow candidates to gain licensure and begin working in healthcare settings where immunological expertise is highly valuable.

By combining immunology studies with these related online degrees, students can enhance their skill sets and improve career prospects in nursing, healthcare research, and clinical roles focusing on immune system health and disease management.

Best Scientists Citing Edwin D. Charlebois

Trending Scientists

Recently Published Articles